Special considerations for the development of drugs for acute clinical mastitis.
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D002417:Cattle; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary; D005260:Female; D007700:Kinetics; D008414:Mastitis, Bovine / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008954:Models, Biological; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary; D013290:Streptococcal Infections / Q000188:drug therapy / Q000378:metabolism / Q000662:veterinary
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000900:Anti-Bacterial Agents